Evogene Expands Research and Development Facilities by Over 50%
Evogene Ltd. announced completion of an expansion program of its R&D facilities, resulting in a greater than 50% increase in the company's gene validation & plant growth capacity. The expansion was conducted in two stages: the first stage included reconstruction of new molecular and tissue culture laboratories; and the second stage included substantial expansion of Evogene's greenhouse site. The total costs for this expansion program was approximately $4.5 million.
The first stage of the program included construction of over 1,100 m2 state-of-the-art molecular and tissue culture laboratories, upgrading and expanding the previous area amount by over 60%. The new laboratories were planned and equipped with Evogene's custom tailored automated instruments for lab processes, with emphasis on cost optimization, international environmental safety standards and energy savings.
The second stage of the program included expansion of Evogene's greenhouse site and was focused on doubling the area amount in the Gezer regional area, located nearby Rehovot. This enables Evogene to substantially increase its plant growth and validation capacity.
In addition, Evogene has initiated an additional building program to provide new office space to support its personnel increase, mainly trait researchers and computational genomics teams. During the past three years, the company more than doubled its employment level. The new office and related facilities are budgeted to cost approximately $1,000,000.
Other news from the department business & finance
